{"ticker": {"uuid": "b79219b5-39bc-4c36-95cf-8340f8cfc02f", "symbol": "5290", "name": "Vertex Corporation", "exchange": "JPX", "country": "JP", "sector": "Basic Materials", "industry": "Building Materials"}, "articles": [{"title": "Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOR1oyV1ZCX1dVV2pwdkVGNGdmT3lnSE9yYmgxbG8zOERzSFFTMFdWQXg3UzUta0ZJeTc4cWdQSkV3MG9DcWlUSmYwejJHbG4zQ3YzWEZRRDhaeWdMUzl5V1Q4d3UyZTAzM2xGR1VtVEZPVlNRbktBRFR2VjdXSG93elpDN2lVb1ZXOVJZ?oc=5", "source_name": "TradingKey", "published_at": "2026-07-08T18:15:18+00:00", "published_display": "08 Jul 2026 18:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal -- Barrons.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQUnhEU0NGTFoweXZ2YTh1WHp6MXRrLVd2TU8xLTlaTW5DWEhDdjVIZHJiUDNXRHNlQTAtU29ST2hFRWYwenJoc3RnWF9pWmtOT19iVGFxWTAzdlVZcjVkUEpRZV8zMUxRRi0zaVZaWUwwcTBaMHFFM0RDMExLU0Nsd2dUY0E1eEMyN0N1LXluWW11UkIwY3Y5cEJFNWJKQQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T18:38:00+00:00", "published_display": "07 Jul 2026 18:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Vertex Corp. \u2013 TSE:5290", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOM1M0SzI4THJSUGZ5NHpiNUZEc1ZQTGJvYmw0NkY1VUUtU0xoenVESHE3aGRLWGh4VldIeTFXclNuLVd6R29JVFAtckEyc1pKTWU5VWlvbGR1aXFidHhVVkkzUW5WSkpJZGdIWU9uenM4a3ZQd2RmN1pWMElSRFpxU25iaDNXdVFKbUFDUU1FOEpqa1NhM2FuWjlrb194bGtTTjhWMlFRY3o?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T18:18:38+00:00", "published_display": "07 Jul 2026 18:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPN1dVS1c2YzRxTTl4RTdXWHdnQmVGbjd1WDFOaGdGaVhWMXdlZlFiYTFuZHh2N010REtMX2RXT1UzVUMwTFF5Qk1uVUJ6NWFQVDM4RU05NTl0a0xqYXNSS3hNUlUxSk1HTzA2XzdwamhPUkQzOFphSGZ1UzFVb3R3WS1GQmtsTFJJTk4zOXdYaC1mSEhYRnBRRWRCaVJNRlgwbUZZUFBPcE9zMEY0N2VUS2d3NHl0YnV0MWxzeGVZWGdWRHFyZTZKZ2JrbEI?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-07T00:07:00+00:00", "published_display": "07 Jul 2026 00:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to buy Crinetics for $10 billion in rare-diseases push", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOX3N1NDFzcDNMSmVSODY1SEJGRm51Sl96QmtwWV9zMHA3RUZTRVlDenhJaG01alZQSU5KZUNWV2NFMFp6c0U5Xy1aZFZ2UXVmNWFGNk1HR1NMcGpJWHVpQjVtQWV2Z0FqMldWWHFwMlA2cHh1eDBtT19sem9BZ1ljblQta09WbWdBcjFzX3JVY2h2WlFsQ1VZ?oc=5", "source_name": "Reuters", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Vertex with Visa: In-Depth Overview Guide", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE8zNUg2UWEwbndBTDE0d3pPMnFZaGx4QmRZbmNsODV0cTdTeGlFYU1WbExtb0tUcFVkVlIzNnVhZmFiQ2wxcmdRWWdtUDhGdmdsTkktR08xeS1QVnE0ZGFIU0JIblFpX3RxSmlxRUh3b3pXN2hIbnk0Qw?oc=5", "source_name": "Kabul University", "published_at": "2026-06-29T17:56:38+00:00", "published_display": "29 Jun 2026 17:56", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Madrigal Pharmaceuticals Could Become The Next Vertex", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPLTl4cTFqMV9mRTgybThWU3VWbUJIVElYOXFzeGRqM195ck5USWoyNUZuZ2RSc3lYdmRSSm16UVJZcDB1aHZ0LVUzYXRaN0hKYTM0MnJ1cUtDNGp6MDdSQm5pa3ZVTWVRSVdEdk4wVTdrbDRCbThyQVdyVDJDUWNjeWRuX25ZWml0cUkwUEJNZGk3Mnp0MzFteGt3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock rallying today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSW1nRnNlajFzc2VkREJqbTJwV2pyNjd0UTdEcHlGblZEamltS0piMlAyRDBuTXA4ekVZVnpRbjRLQW04TjlaUWRnWndWYm9Bb2F3ZGI3cU5HQnd6Qk5kMk5WSVpUc1h0bVBMNDh4R0lXX3drNkVjSVFRNms0ZTFIM1p5NTVvTVJFa18zWHZPQWZIUm5UNE5LaXlNLXRjRXktQzFjMWVMZDN3T19LZnl2dA?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Announces Approval of 2026 Stock a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNQ2ROSzJaeDBkY3I0bjRrYkhQbDJTenlKaFBidzNjWkxndk5pME9ILXVRNUYxdUlGMmdpcmhkZmRxaU1qUG50MXNSWm40bFZPZ0IxTG1LOWdvM0JNTWNkVkFLdWdBYkxueHZ2WWdTZUlfTEdtcDVoVEZ2dlotczcxTXg0RVFra25ZYVVpbXp2dWV4MWhkZ0k4RnZnVXhMZWRQb3U1ck1xWU9YNDRDZkRTUkFJNDJ3dEM5WFJWcWxPR3VqTVpjaGc?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "V2X, INC. ANNOUNCES PRICING OF OFFERING OF APPROXIMATELY 2.0 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxPY3FlUEJQaFNoZkVoSkJpSXB6QmlRSlZUY09sejRUdkc5Y2psQUdnMDFwelR0TzdPcmNGT3YyVVJvUUhGLXNoak44eTgwSnpMQWxfWGpkekZpTUR2U0VZQ01ZNTlvcHA0S1Z0VERINjRoeENaWHBOY1Y5SjExeFNxM2Y1MmExa0tjMGQ5WUhyYm80eVFVRnU0Y2ZGd3pSUW02V3NzWVlIOGhYNUN4N0FxWVV6c0NuRUtpeGV1N2gtV3ZsV3RMaURqWVh1Uzd4eHh5WWY0aVpnbHdMS1dsYmduVkt2Q2g0YkVoakFsWDZweTh5ckhFNGJFNUJRSmwydXhhRTFaNkc5MXhYTm03UE9UdWdicnY0dw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Pops 5% On Successful Late Stage Kidney Disease Drug Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxON3huRVNtLUZSdmZJR3AzZ1BJNlZfV3haaFBfRy1YMXFiYzV3NElYWlZyMHpqTXpSWTBXWGtfSHEzM0pkYWZpRWdqSENTeXA2RnhzZ3RGb1BuR1poVHV2Q3VyZ2lFN1ZZTC1MM0w3S2VQZ2tudllsYUpwQjBhcFMtbGhFT0tZaUtsSmF5QzY3RkNuMkFRZ3Z4dGEzVjVVU2tlNl9zNk41V2toQXlSQmlONnZOYmNRWWRY?oc=5", "source_name": "TIKR.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "S&P 500 Futures Steady in Premarket Trading; Vertex Pharmaceuticals, UFP Industries Lead", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNcVdBTU1QUWNDQlNpRldJNXZFbHgtcmpkTjQ5Z1R6eUpaX0NHX1NTNEJUb0RSUE9TdXU5TVQxN0VBeEl5bGpOZXZOWU1Bc2g4Wkl2azYzLW8tTzJ4dlpkaWFvX3hRYWdKakJlaWoyY2hROG5ud0RJUExZbGVKem5ZMFVuUzVmdlBacGhPS0EtNnZXbktZMUdkZXdxdkNWbXQyQjR0d2RNbDdSSktmUUtiVmdjQXdvSFpCVU5VZEMzYWtmd0xTZ0Rv?oc=5", "source_name": "Barron's", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex passes key test in quest to treat kidney diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOakJlLWZZMV85OXlxWmc3MmV6Vl9qN1dlWlBzRjZWLU5jVi00SkVibmV4LVpPTUFkNnplLV9xYjZaampLSEZRS1Q2UUVjeWp4aGhVa084SHg3YW82NjZCMDJUUUE5WlZYcVJzcnBKSG9UOXFPUXV2N1FVb2liUVV2VFE3UzBmMFBTdjc1cW9IdnFVUdIBlwFBVV95cUxOWUJ2QXRMQUtSRHhlQXN0RkczNEE0aWxTdWxORTNyYUxHNHhCMWhWNUJiVjVyakRxSnM3UDh0ak5kbDNwRkl4QzRxR0lHWTh6TjRXUjBJd3JPejg3bHpSWFZQaEI1emVVVEdCM214elZmdGRaUEFxUkdtWF9EVmp1d2JLM0w3TU16a1E0WEhwQVdQMVZ6Z0dR?oc=5", "source_name": "CNBC", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMUxjTEUwRWhBQmxlYXlaVTRqY1NuMEFpX0pFR3ltQmVnVXUwdEtFbEhoUkswZ1NoYW5QbVhSUTM3anpxclI5d2NzSlIwSjg1a0d6cGdOTUg4ZEF3U0IyN0NtLUg2eGxucldIajMzN1lIaFFmNnprWlFYZWRSdjVpaHVPYW0xOWhUdmhv?oc=5", "source_name": "Time Magazine", "published_at": "2026-01-07T17:42:38+00:00", "published_display": "07 Jan 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "V2X, INC. ANNOUNCES SALE OF 2,000,000 SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNT3NodV84Vm80cEl4NGdKRlQ0c3NPeTlJaG1tejBQallLRlV6Rl9pVGdqSk03V1BLU2xkeUx1SUhQbDlLem14ZjE0eFVPLWM1N21YVmt1TWs0aWx0dXVLdXJFRzJGczB5TUpCOERvVDRHNVpKdTd6NVpUdXpWam15cGo1bVI0ZmxqT05meEQ4RmVESGpuNmZ3NG5wb05ORzQ4MnZwRFN3bWFGbXdYdVhVZGlJQ0JuU0pKNXlaNjQwaWxFaGg1dzI1UXZxQWtadzZjTWpOYmVWbWk1cVo2TDBtVUFvcHZaSkVpUVgySw?oc=5", "source_name": "PR Newswire", "published_at": "2025-05-15T07:00:00+00:00", "published_display": "15 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOR1oyV1ZCX1dVV2pwdkVGNGdmT3lnSE9yYmgxbG8zOERzSFFTMFdWQXg3UzUta0ZJeTc4cWdQSkV3MG9DcWlUSmYwejJHbG4zQ3YzWEZRRDhaeWdMUzl5V1Q4d3UyZTAzM2xGR1VtVEZPVlNRbktBRFR2VjdXSG93elpDN2lVb1ZXOVJZ?oc=5", "source_name": "TradingKey", "published_at": "2026-07-08T18:15:18+00:00", "published_display": "08 Jul 2026 18:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal -- Barrons.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQUnhEU0NGTFoweXZ2YTh1WHp6MXRrLVd2TU8xLTlaTW5DWEhDdjVIZHJiUDNXRHNlQTAtU29ST2hFRWYwenJoc3RnWF9pWmtOT19iVGFxWTAzdlVZcjVkUEpRZV8zMUxRRi0zaVZaWUwwcTBaMHFFM0RDMExLU0Nsd2dUY0E1eEMyN0N1LXluWW11UkIwY3Y5cEJFNWJKQQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T18:38:00+00:00", "published_display": "07 Jul 2026 18:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Vertex Corp. \u2013 TSE:5290", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOM1M0SzI4THJSUGZ5NHpiNUZEc1ZQTGJvYmw0NkY1VUUtU0xoenVESHE3aGRLWGh4VldIeTFXclNuLVd6R29JVFAtckEyc1pKTWU5VWlvbGR1aXFidHhVVkkzUW5WSkpJZGdIWU9uenM4a3ZQd2RmN1pWMElSRFpxU25iaDNXdVFKbUFDUU1FOEpqa1NhM2FuWjlrb194bGtTTjhWMlFRY3o?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T18:18:38+00:00", "published_display": "07 Jul 2026 18:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPN1dVS1c2YzRxTTl4RTdXWHdnQmVGbjd1WDFOaGdGaVhWMXdlZlFiYTFuZHh2N010REtMX2RXT1UzVUMwTFF5Qk1uVUJ6NWFQVDM4RU05NTl0a0xqYXNSS3hNUlUxSk1HTzA2XzdwamhPUkQzOFphSGZ1UzFVb3R3WS1GQmtsTFJJTk4zOXdYaC1mSEhYRnBRRWRCaVJNRlgwbUZZUFBPcE9zMEY0N2VUS2d3NHl0YnV0MWxzeGVZWGdWRHFyZTZKZ2JrbEI?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-07T00:07:00+00:00", "published_display": "07 Jul 2026 00:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex to buy Crinetics for $10 billion in rare-diseases push", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOX3N1NDFzcDNMSmVSODY1SEJGRm51Sl96QmtwWV9zMHA3RUZTRVlDenhJaG01alZQSU5KZUNWV2NFMFp6c0U5Xy1aZFZ2UXVmNWFGNk1HR1NMcGpJWHVpQjVtQWV2Z0FqMldWWHFwMlA2cHh1eDBtT19sem9BZ1ljblQta09WbWdBcjFzX3JVY2h2WlFsQ1VZ?oc=5", "source_name": "Reuters", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Vertex with Visa: In-Depth Overview Guide", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE8zNUg2UWEwbndBTDE0d3pPMnFZaGx4QmRZbmNsODV0cTdTeGlFYU1WbExtb0tUcFVkVlIzNnVhZmFiQ2wxcmdRWWdtUDhGdmdsTkktR08xeS1QVnE0ZGFIU0JIblFpX3RxSmlxRUh3b3pXN2hIbnk0Qw?oc=5", "source_name": "Kabul University", "published_at": "2026-06-29T17:56:38+00:00", "published_display": "29 Jun 2026 17:56", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Madrigal Pharmaceuticals Could Become The Next Vertex", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPLTl4cTFqMV9mRTgybThWU3VWbUJIVElYOXFzeGRqM195ck5USWoyNUZuZ2RSc3lYdmRSSm16UVJZcDB1aHZ0LVUzYXRaN0hKYTM0MnJ1cUtDNGp6MDdSQm5pa3ZVTWVRSVdEdk4wVTdrbDRCbThyQVdyVDJDUWNjeWRuX25ZWml0cUkwUEJNZGk3Mnp0MzFteGt3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock rallying today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSW1nRnNlajFzc2VkREJqbTJwV2pyNjd0UTdEcHlGblZEamltS0piMlAyRDBuTXA4ekVZVnpRbjRLQW04TjlaUWRnWndWYm9Bb2F3ZGI3cU5HQnd6Qk5kMk5WSVpUc1h0bVBMNDh4R0lXX3drNkVjSVFRNms0ZTFIM1p5NTVvTVJFa18zWHZPQWZIUm5UNE5LaXlNLXRjRXktQzFjMWVMZDN3T19LZnl2dA?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Announces Approval of 2026 Stock a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNQ2ROSzJaeDBkY3I0bjRrYkhQbDJTenlKaFBidzNjWkxndk5pME9ILXVRNUYxdUlGMmdpcmhkZmRxaU1qUG50MXNSWm40bFZPZ0IxTG1LOWdvM0JNTWNkVkFLdWdBYkxueHZ2WWdTZUlfTEdtcDVoVEZ2dlotczcxTXg0RVFra25ZYVVpbXp2dWV4MWhkZ0k4RnZnVXhMZWRQb3U1ck1xWU9YNDRDZkRTUkFJNDJ3dEM5WFJWcWxPR3VqTVpjaGc?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "V2X, INC. ANNOUNCES PRICING OF OFFERING OF APPROXIMATELY 2.0 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxPY3FlUEJQaFNoZkVoSkJpSXB6QmlRSlZUY09sejRUdkc5Y2psQUdnMDFwelR0TzdPcmNGT3YyVVJvUUhGLXNoak44eTgwSnpMQWxfWGpkekZpTUR2U0VZQ01ZNTlvcHA0S1Z0VERINjRoeENaWHBOY1Y5SjExeFNxM2Y1MmExa0tjMGQ5WUhyYm80eVFVRnU0Y2ZGd3pSUW02V3NzWVlIOGhYNUN4N0FxWVV6c0NuRUtpeGV1N2gtV3ZsV3RMaURqWVh1Uzd4eHh5WWY0aVpnbHdMS1dsYmduVkt2Q2g0YkVoakFsWDZweTh5ckhFNGJFNUJRSmwydXhhRTFaNkc5MXhYTm03UE9UdWdicnY0dw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Pops 5% On Successful Late Stage Kidney Disease Drug Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxON3huRVNtLUZSdmZJR3AzZ1BJNlZfV3haaFBfRy1YMXFiYzV3NElYWlZyMHpqTXpSWTBXWGtfSHEzM0pkYWZpRWdqSENTeXA2RnhzZ3RGb1BuR1poVHV2Q3VyZ2lFN1ZZTC1MM0w3S2VQZ2tudllsYUpwQjBhcFMtbGhFT0tZaUtsSmF5QzY3RkNuMkFRZ3Z4dGEzVjVVU2tlNl9zNk41V2toQXlSQmlONnZOYmNRWWRY?oc=5", "source_name": "TIKR.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "S&P 500 Futures Steady in Premarket Trading; Vertex Pharmaceuticals, UFP Industries Lead", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNcVdBTU1QUWNDQlNpRldJNXZFbHgtcmpkTjQ5Z1R6eUpaX0NHX1NTNEJUb0RSUE9TdXU5TVQxN0VBeEl5bGpOZXZOWU1Bc2g4Wkl2azYzLW8tTzJ4dlpkaWFvX3hRYWdKakJlaWoyY2hROG5ud0RJUExZbGVKem5ZMFVuUzVmdlBacGhPS0EtNnZXbktZMUdkZXdxdkNWbXQyQjR0d2RNbDdSSktmUUtiVmdjQXdvSFpCVU5VZEMzYWtmd0xTZ0Rv?oc=5", "source_name": "Barron's", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex passes key test in quest to treat kidney diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOakJlLWZZMV85OXlxWmc3MmV6Vl9qN1dlWlBzRjZWLU5jVi00SkVibmV4LVpPTUFkNnplLV9xYjZaampLSEZRS1Q2UUVjeWp4aGhVa084SHg3YW82NjZCMDJUUUE5WlZYcVJzcnBKSG9UOXFPUXV2N1FVb2liUVV2VFE3UzBmMFBTdjc1cW9IdnFVUdIBlwFBVV95cUxOWUJ2QXRMQUtSRHhlQXN0RkczNEE0aWxTdWxORTNyYUxHNHhCMWhWNUJiVjVyakRxSnM3UDh0ak5kbDNwRkl4QzRxR0lHWTh6TjRXUjBJd3JPejg3bHpSWFZQaEI1emVVVEdCM214elZmdGRaUEFxUkdtWF9EVmp1d2JLM0w3TU16a1E0WEhwQVdQMVZ6Z0dR?oc=5", "source_name": "CNBC", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMUxjTEUwRWhBQmxlYXlaVTRqY1NuMEFpX0pFR3ltQmVnVXUwdEtFbEhoUkswZ1NoYW5QbVhSUTM3anpxclI5d2NzSlIwSjg1a0d6cGdOTUg4ZEF3U0IyN0NtLUg2eGxucldIajMzN1lIaFFmNnprWlFYZWRSdjVpaHVPYW0xOWhUdmhv?oc=5", "source_name": "Time Magazine", "published_at": "2026-01-07T17:42:38+00:00", "published_display": "07 Jan 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "V2X, INC. ANNOUNCES SALE OF 2,000,000 SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNT3NodV84Vm80cEl4NGdKRlQ0c3NPeTlJaG1tejBQallLRlV6Rl9pVGdqSk03V1BLU2xkeUx1SUhQbDlLem14ZjE0eFVPLWM1N21YVmt1TWs0aWx0dXVLdXJFRzJGczB5TUpCOERvVDRHNVpKdTd6NVpUdXpWam15cGo1bVI0ZmxqT05meEQ4RmVESGpuNmZ3NG5wb05ORzQ4MnZwRFN3bWFGbXdYdVhVZGlJQ0JuU0pKNXlaNjQwaWxFaGg1dzI1UXZxQWtadzZjTWpOYmVWbWk1cVo2TDBtVUFvcHZaSkVpUVgySw?oc=5", "source_name": "PR Newswire", "published_at": "2025-05-15T07:00:00+00:00", "published_display": "15 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 18, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 14, "score": 54, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 8.0, "count": 12}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1358.0, "latest_week": "2026-07-10", "one_week_move": 0.8, "four_week_move": -5.3, "twelve_week_move": -30.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.141758, "market_dynamics_buy_signal": false, "relative_strength": -31.345085, "fair_value_gap": 26.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 50.2703, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.8% over one week, -5.3% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "IndexBox", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "TradingKey", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Stocktwits", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Kabul University", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Deals and strategy", "count": 2}, {"label": "Earnings", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.8% over one week, -5.3% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled"}], "updated_at": "2026-07-17T10:04:36.944544+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}